Richard Lee - Profile and Investment Details

Investor Profile

Richard Lee is a Venture Capital, Private Equity Firm, Investor based in United Kingdom with a diverse investment portfolio that includes companies such as Gadeta, SuperX, Critical Pressure, Impact Biomedicines, Inexia, Aura Biosciences, Janpix, Alderaan Biotechnology, ApcinteX, Yukin Therapeutics, Xenikos, Palladio Biosciences, Mavalon Therapeutics, Kymo Therapeutics, Sydnexis, Z Factor, Stealthyx Therapeutics, Checkmate Pharmaceuticals, Orexia, Vaxcyte, Morphogen-IX, Phathom Pharmaceuticals, Diasome Pharmaceuticals, Capella BioScience, Divide and Conquer, Synthorx, Breakpoint Therapeutics, . Over time, Richard Lee has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Richard Lee is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Drug Discovery, E-commerce, Wellness, Women Founded, Cryptocurrency, Life Science, Portfolio Management, Marketplace, Venture Fundraising, Finance, Biotechnology, Consumer Health, Drug Development, Hispanic / Latinx Founded, Electronic Health Records (EHR), Health and Hospital Services, Productivity Software, Clinical Trials, FinTech, Reviews and Recommendations, Logistics, Regulatory Compliance, Medical, B2B, Real Estate, Therapeutics, App Discovery, Pharmaceuticals may find it worthwhile to explore potential connections with Richard Lee, as their portfolio suggests a familiarity and interest in this area.

Understanding Richard Lee’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.